InspireMD, Inc. has successfully closed a stock offering that raised approximately $34.9 million in net proceeds. This move is significant for the company as it strengthens its financial position and supports its growth initiatives.

The offering included 7,342,308 shares of common stock and pre-funded warrants to purchase up to 50,350,000 shares. Additionally, it featured Series L warrants to purchase up to 43,269,231 shares of common stock. The offering was made under the company's effective automatic shelf registration statement previously filed with the SEC.

On November 18, 2026, Lake Street Capital Markets, LLC, the representative of the underwriters, exercised a 30-day option to purchase additional shares, resulting in an additional $5.3 million raised. This option included up to 8,635,846 shares and warrants to purchase up to 6,490,384 shares.

InspireMD, Inc., incorporated in Delaware, operates in the surgical and medical instruments and apparatus industry, as classified under SIC code 3841. The company trades on the Nasdaq under the ticker symbol NSPR.

The successful completion of this offering may positively impact InspireMD's competitive positioning within the industry. As the company enhances its capabilities, it may prompt responses from competitors who will need to adapt to the evolving market landscape.

Looking ahead, it remains to be seen how InspireMD will allocate the newly raised capital and what strategic initiatives they will pursue. The filing does not specify what happens next.